Role of Selenoproteins in Redox Regulation of Signaling and the Antioxidant System: A Review
Abstract
:1. Introduction
2. Selenocysteine in Selenoproteins
3. Glutathione Peroxidase
4. Thioredoxin Reductase
5. Selenoprotein R
6. Selenoprotein O
7. Other Selenoproteins
8. Conclusions
Author Contributions
Funding
Conflicts of Interest
References
- Valko, M.; Rhodes, C.J.; Moncol, J.; Izakovic, M.; Mazur, M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem. Biol. Interact. 2006, 160, 1–40. [Google Scholar] [CrossRef] [PubMed]
- Valko, M.; Leibfritz, D.; Moncol, J.; Cronin, M.T.; Mazur, M.; Telser, J. Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 2007, 39, 44–84. [Google Scholar] [CrossRef] [PubMed]
- Dalle-Donne, I.; Rossi, R.; Colombo, R.; Giustarini, D.; Milzani, A. Biomarkers of oxidative damage in human disease. Clin. Chem. 2006, 52, 601–623. [Google Scholar] [CrossRef] [PubMed]
- Dhalla, N.S.; Temsah, R.M.; Netticadan, T. Role of oxidative stress in cardiovascular diseases. J. hypertens. 2000, 18, 655–673. [Google Scholar] [CrossRef]
- Jenner, P. Oxidative stress in Parkinson’s disease. Ann. Neurol. 2003, 53 (Suppl. 3), S26–S36; discussion S36–S38. [Google Scholar] [CrossRef]
- Sayre, L.M.; Smith, M.A.; Perry, G. Chemistry and biochemistry of oxidative stress in neurodegenerative disease. Curr. Med. Chem. 2001, 8, 721–738. [Google Scholar] [CrossRef]
- Brownlee, M.; Cerami, A. The biochemistry of the complications of diabetes mellitus. Annu. Rev. Biochem. 1981, 50, 385–432. [Google Scholar] [CrossRef]
- Kasparova, S.; Brezova, V.; Valko, M.; Horecky, J.; Mlynarik, V.; Liptaj, T.; Vancova, O.; Ulicna, O.; Dobrota, D. Study of the oxidative stress in a rat model of chronic brain hypoperfusion. Neurochem. Int. 2005, 46, 601–611. [Google Scholar] [CrossRef]
- Harman, D. Aging: A theory based on free radical and radiation chemistry. J. gerontol. 1956, 11, 298–300. [Google Scholar] [CrossRef] [Green Version]
- Choi, S.M.; Kim, D.-H.; Chun, K.-S.; Choi, J.-S. Carnosol induces apoptotic cell death through ROS-dependent inactivation of STAT3 in human melanoma G361 cells. Appl. Biol. Chem. 2019, 62. [Google Scholar] [CrossRef]
- Utaipan, T.; Boonyanuphong, P.; Chuprajob, T.; Suksamrarn, A.; Chunglok, W. A trienone analog of curcumin, 1,7-bis(3-hydroxyphenyl)-1,4,6-heptatrien-3-one, possesses ROS- and caspase-mediated apoptosis in human oral squamous cell carcinoma cells in vitro. Appl. Biol. Chem. 2020, 63. [Google Scholar] [CrossRef]
- Avery, J.C.; Hoffmann, P.R. Selenium, Selenoproteins, and Immunity. Nutrients 2018, 10, 1203. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Wang, N.; Tan, H.Y.; Li, S.; Xu, Y.; Guo, W.; Feng, Y. Supplementation of Micronutrient Selenium in Metabolic Diseases: Its Role as an Antioxidant. Oxid. Med. Cell Longev. 2017, 2017, 7478523. [Google Scholar] [CrossRef] [PubMed]
- Wessjohann, L.A.; Schneider, A.; Abbas, M.; Brandt, W. Selenium in chemistry and biochemistry in comparison to sulfur. Biol. Chem. 2007, 388, 997–1006. [Google Scholar] [CrossRef]
- Lobanov, A.V.; Hatfield, D.L.; Gladyshev, V.N. Eukaryotic selenoproteins and selenoproteomes. Biochim. et biophy. acta 2009, 1790, 1424–1428. [Google Scholar] [CrossRef] [Green Version]
- Gromer, S.; Wissing, J.; Behne, D.; Ashman, K.; Schirmer, R.H.; Flohe, L.; Becker, K. A hypothesis on the catalytic mechanism of the selenoenzyme thioredoxin reductase. Biochem. J. 1998, 332, 591–592. [Google Scholar] [CrossRef] [Green Version]
- Gorlatov, S.N.; Stadtman, T.C. Human selenium-dependent thioredoxin reductase from HeLa cells: Properties of forms with differing heparin affinities. Arch. Biochem. Biophys. 1999, 369, 133–142. [Google Scholar] [CrossRef]
- Chung, S.S.; Kim, M.; Youn, B.S.; Lee, N.S.; Park, J.W.; Lee, I.K.; Lee, Y.S.; Kim, J.B.; Cho, Y.M.; Lee, H.K.; et al. Glutathione peroxidase 3 mediates the antioxidant effect of peroxisome proliferator-activated receptor gamma in human skeletal muscle cells. Mol. Cell. Biol. 2009, 29, 20–30. [Google Scholar] [CrossRef] [Green Version]
- Lee, S.R.; Bar-Noy, S.; Kwon, J.; Levine, R.L.; Stadtman, T.C.; Rhee, S.G. Mammalian thioredoxin reductase: Oxidation of the C-terminal cysteine/selenocysteine active site forms a thioselenide, and replacement of selenium with sulfur markedly reduces catalytic activity. Proc. Natl. Acad. Sci. USA 2000, 97, 2521–2526. [Google Scholar] [CrossRef] [Green Version]
- Quan, S.; Schneider, I.; Pan, J.; Von Hacht, A.; Bardwell, J.C. The CXXC motif is more than a redox rheostat. J. Biol. Chem. 2007, 282, 28823–28833. [Google Scholar] [CrossRef] [Green Version]
- Johansson, L.; Gafvelin, G.; Arner, E.S. Selenocysteine in proteins-properties and biotechnological use. Biochim. biophy. Acta 2005, 1726, 1–13. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Berry, M.J.; Banu, L.; Chen, Y.Y.; Mandel, S.J.; Kieffer, J.D.; Harney, J.W.; Larsen, P.R. Recognition of UGA as a selenocysteine codon in type I deiodinase requires sequences in the 3’ untranslated region. Nature 1991, 353, 273–276. [Google Scholar] [CrossRef] [PubMed]
- Bellinger, F.P.; Raman, A.V.; Reeves, M.A.; Berry, M.J. Regulation and function of selenoproteins in human disease. Biochem. J. 2009, 422, 11–22. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Mattmiller, S.A.; Carlson, B.A.; Sordillo, L.M. Regulation of inflammation by selenium and selenoproteins: Impact on eicosanoid biosynthesis. J. Nutr. Sci. 2013, 2, e28. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Fairweather-Tait, S.J.; Collings, R.; Hurst, R. Selenium bioavailability: Current knowledge and future research requirements. Am. J. Clin. Nutr. 2010, 91, 1484S–1491S. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Hatfield, D.L.; Gladyshev, V.N. How selenium has altered our understanding of the genetic code. Mol. Cell. Biol. 2002, 22, 3565–3576. [Google Scholar] [CrossRef] [Green Version]
- Spallholz, J.E. Selenomethionine and Methioninase: Selenium Free Radical Anticancer Activity. Methods Mol. Biol. 2019, 1866, 199–210. [Google Scholar] [CrossRef]
- Luchman, H.A.; Villemaire, M.L.; Bismar, T.A.; Carlson, B.A.; Jirik, F.R. Prostate epithelium-specific deletion of the selenocysteine tRNA gene Trsp leads to early onset intraepithelial neoplasia. Am. J. Pathol. 2014, 184, 871–877. [Google Scholar] [CrossRef] [Green Version]
- Bosl, M.R.; Takaku, K.; Oshima, M.; Nishimura, S.; Taketo, M.M. Early embryonic lethality caused by targeted disruption of the mouse selenocysteine tRNA gene (Trsp). Proc. Natl. Acad. Sci. USA 1997, 94, 5531–5534. [Google Scholar] [CrossRef] [Green Version]
- Kumaraswamy, E.; Carlson, B.A.; Morgan, F.; Miyoshi, K.; Robinson, G.W.; Su, D.; Wang, S.; Southon, E.; Tessarollo, L.; Lee, B.J.; et al. Selective removal of the selenocysteine tRNA [Ser]Sec gene (Trsp) in mouse mammary epithelium. Mol. Cell. Biol. 2003, 23, 1477–1488. [Google Scholar] [CrossRef] [Green Version]
- Papp, L.V.; Lu, J.; Holmgren, A.; Khanna, K.K. From selenium to selenoproteins: Synthesis, identity, and their role in human health. Antioxid. Redox Signal. 2007, 9, 775–806. [Google Scholar] [CrossRef] [PubMed]
- Burk, R.F.; Hill, K.E. Selenoprotein P: An extracellular protein with unique physical characteristics and a role in selenium homeostasis. Annu. Rev. Nutr. 2005, 25, 215–235. [Google Scholar] [CrossRef] [PubMed]
- Qi, Y.; Grishin, N.V. Structural classification of thioredoxin-like fold proteins. Proteins 2005, 58, 376–388. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Chivers, P.T.; Prehoda, K.E.; Raines, R.T. The CXXC motif: A rheostat in the active site. Biochemistry 1997, 36, 4061–4066. [Google Scholar] [CrossRef]
- Chivers, P.T.; Laboissiere, M.C.; Raines, R.T. The CXXC motif: Imperatives for the formation of native disulfide bonds in the cell. EMBO J. 1996, 15, 2659–2667. [Google Scholar] [CrossRef]
- Reeves, M.A.; Hoffmann, P.R. The human selenoproteome: Recent insights into functions and regulation. Cell. Mol. Life Sci. 2009, 66, 2457–2478. [Google Scholar] [CrossRef] [Green Version]
- Lee, B.C.; Peterfi, Z.; Hoffmann, F.W.; Moore, R.E.; Kaya, A.; Avanesov, A.; Tarrago, L.; Zhou, Y.; Weerapana, E.; Fomenko, D.E.; et al. MsrB1 and MICALs regulate actin assembly and macrophage function via reversible stereoselective methionine oxidation. Mol. Cell. 2013, 51, 397–404. [Google Scholar] [CrossRef] [Green Version]
- Hawkes, W.C.; Alkan, Z. Regulation of redox signaling by selenoproteins. Biol. Trace Elem. Res. 2010, 134, 235–251. [Google Scholar] [CrossRef] [Green Version]
- Kieliszek, M.; Blazejak, S. Selenium: Significance, and outlook for supplementation. Nutrition 2013, 29, 713–718. [Google Scholar] [CrossRef]
- Hu, Y.; Benya, R.V.; Carroll, R.E.; Diamond, A.M. Allelic loss of the gene for the GPX1 selenium-containing protein is a common event in cancer. J. Nutr. 2005, 135, 3021s–3024s. [Google Scholar] [CrossRef]
- Hu, Y.J.; Diamond, A.M. Role of glutathione peroxidase 1 in breast cancer: Loss of heterozygosity and allelic differences in the response to selenium. Cancer Res. 2003, 63, 3347–3351. [Google Scholar] [PubMed]
- El Haddad, M.; Jean, E.; Turki, A.; Hugon, G.; Vernus, B.; Bonnieu, A.; Passerieux, E.; Hamade, A.; Mercier, J.; Laoudj-Chenivesse, D.; et al. Glutathione peroxidase 3, a new retinoid target gene, is crucial for human skeletal muscle precursor cell survival. J. cell Sci. 2012, 125, 6147–6156. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Hoffmann, F.W.; Hashimoto, A.S.; Lee, B.C.; Rose, A.H.; Shohet, R.V.; Hoffmann, P.R. Specific antioxidant selenoproteins are induced in the heart during hypertrophy. Arch. Biochem. Biophys. 2011, 512, 38–44. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Tanguy, S.; Rakotovao, A.; Jouan, M.G.; Ghezzi, C.; de Leiris, J.; Boucher, F. Dietary selenium intake influences Cx43 dephosphorylation, TNF-alpha expression and cardiac remodeling after reperfused infarction. Mol. Nut. Food Res. 2011, 55, 522–529. [Google Scholar] [CrossRef]
- Carlson, B.A.; Tobe, R.; Yefremova, E.; Tsuji, P.A.; Hoffmann, V.J.; Schweizer, U.; Gladyshev, V.N.; Hatfield, D.L.; Conrad, M. Glutathione peroxidase 4 and vitamin E cooperatively prevent hepatocellular degeneration. Redox Boil. 2016, 9, 22–31. [Google Scholar] [CrossRef] [Green Version]
- Zachara, B.A.; Gromadzinska, J.; Zbrog, Z.; Swiech, R.; Wasowicz, W.; Twardowska, E.; Jablonska, E.; Sobala, W. Selenium supplementation to chronic kidney disease patients on hemodialysis does not induce the synthesis of plasma glutathione peroxidase. Acta Biochim. Pol. 2009, 56, 183–187. [Google Scholar] [CrossRef]
- Taccone-Gallucci, M.; Noce, A.; Bertucci, P.; Fabbri, C.; Manca-di-Villahermosa, S.; Della-Rovere, F.R.; De Francesco, M.; Lonzi, M.; Federici, G.; Scaccia, F.; et al. Chronic treatment with statins increases the availability of selenium in the antioxidant defence systems of hemodialysis patients. J. Trace Elem. Med. Biol. 2010, 24, 27–30. [Google Scholar] [CrossRef] [Green Version]
- Cardoso, B.R.; Hare, D.J.; Bush, A.I.; Roberts, B.R. Glutathione peroxidase 4: A new player in neurodegeneration? Mol. Psychiatry 2017, 22, 328–335. [Google Scholar] [CrossRef] [Green Version]
- Hambright, W.S.; Fonseca, R.S.; Chen, L.; Na, R.; Ran, Q. Ablation of ferroptosis regulator glutathione peroxidase 4 in forebrain neurons promotes cognitive impairment and neurodegeneration. Redox Boil. 2017, 12, 8–17. [Google Scholar] [CrossRef]
- Chen, L.; Hambright, W.S.; Na, R.; Ran, Q. Ablation of the Ferroptosis Inhibitor Glutathione Peroxidase 4 in Neurons Results in Rapid Motor Neuron Degeneration and Paralysis. J. Boil. Chem. 2015, 290, 28097–28106. [Google Scholar] [CrossRef] [Green Version]
- Matsushita, M.; Freigang, S.; Schneider, C.; Conrad, M.; Bornkamm, G.W.; Kopf, M. T cell lipid peroxidation induces ferroptosis and prevents immunity to infection. J. Exp. Med. 2015, 212, 555–568. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Gromer, S.; Eubel, J.K.; Lee, B.L.; Jacob, J. Human selenoproteins at a glance. Cell. Mol. Life Sci. 2005, 62, 2414–2437. [Google Scholar] [CrossRef] [PubMed]
- Neiers, F.; Sonkaria, S.; Olry, A.; Boschi-Muller, S.; Branlant, G. Characterization of the amino acids from Neisseria meningitidis methionine sulfoxide reductase B involved in the chemical catalysis and substrate specificity of the reductase step. J. Boil. Chem. 2007, 282, 32397–32405. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kryukov, G.V.; Castellano, S.; Novoselov, S.V.; Lobanov, A.V.; Zehtab, O.; Guigo, R.; Gladyshev, V.N. Characterization of mammalian selenoproteomes. Science 2003, 300, 1439–1443. [Google Scholar] [CrossRef] [Green Version]
- Sunde, R.A.; Raines, A.M.; Barnes, K.M.; Evenson, J.K. Selenium status highly regulates selenoprotein mRNA levels for only a subset of the selenoproteins in the selenoproteome. Biosci. Rep. 2009, 29, 329–338. [Google Scholar] [CrossRef] [Green Version]
- Moscow, J.A.; Schmidt, L.; Ingram, D.T.; Gnarra, J.; Johnson, B.; Cowan, K.H. Loss of heterozygosity of the human cytosolic glutathione peroxidase I gene in lung cancer. Carcinogenesis 1994, 15, 2769–2773. [Google Scholar] [CrossRef] [Green Version]
- Hardell, L.; Degerman, A.; Tomic, R.; Marklund, S.L.; Bergfors, M. Levels of selenium in plasma and glutathione peroxidase in erythrocytes in patients with prostate cancer or benign hyperplasia. Asian Pac. J. Cancer Prev. 1995, 4, 91–95. [Google Scholar] [CrossRef]
- Ichimura, Y.; Habuchi, T.; Tsuchiya, N.; Wang, L.; Oyama, C.; Sato, K.; Nishiyama, H.; Ogawa, O.; Kato, T. Increased risk of bladder cancer associated with a glutathione peroxidase 1 codon 198 variant. J. Urol. 2004, 172, 728–732. [Google Scholar] [CrossRef]
- Wingler, K.; Muller, C.; Schmehl, K.; Florian, S.; Brigelius-Flohe, R. Gastrointestinal glutathione peroxidase prevents transport of lipid hydroperoxides in CaCo-2 cells. Gastroenterology 2000, 119, 420–430. [Google Scholar] [CrossRef]
- Roman, M.; Jitaru, P.; Barbante, C. Selenium biochemistry and its role for human health. Metallomics 2014, 6, 25–54. [Google Scholar] [CrossRef]
- Florian, S.; Krehl, S.; Loewinger, M.; Kipp, A.; Banning, A.; Esworthy, S.; Chu, F.F.; Brigelius-Flohe, R. Loss of GPx2 increases apoptosis, mitosis, and GPx1 expression in the intestine of mice. Free Radic Boil. Med. 2010, 49, 1694–1702. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Barrett, C.W.; Ning, W.; Chen, X.; Smith, J.J.; Washington, M.K.; Hill, K.E.; Coburn, L.A.; Peek, R.M.; Chaturvedi, R.; Wilson, K.T.; et al. Tumor suppressor function of the plasma glutathione peroxidase gpx3 in colitis-associated carcinoma. Cancer Res. 2013, 73, 1245–1255. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- An, B.C.; Jung, N.-K.; Park, C.Y.; Oh, I.-J.; Choi, Y.-D.; Park, J.-I.; Lee, S.-W. Epigenetic and Glucocorticoid Receptor-Mediated Regulation of Glutathione Peroxidase 3 in Lung Cancer Cells. Mol. Cells 2016, 39, 631–638. [Google Scholar] [CrossRef] [Green Version]
- Chen, B.; Rao, X.; House, M.G.; Nephew, K.P.; Cullen, K.J.; Guo, Z. GPx3 promoter hypermethylation is a frequent event in human cancer and is associated with tumorigenesis and chemotherapy response. Cancer Lett. 2011, 309, 37–45. [Google Scholar] [CrossRef] [PubMed]
- Mohamed, M.M.; Sabet, S.; Peng, D.F.; Nouh, M.A.; El-Shinawi, M.; El-Rifai, W. Promoter hypermethylation and suppression of glutathione peroxidase 3 are associated with inflammatory breast carcinogenesis. Oxid Med Cell Longev. 2014, 2014, 787195. [Google Scholar] [CrossRef] [PubMed]
- Langhardt, J.; Flehmig, G.; Kloting, N.; Lehmann, S.; Ebert, T.; Kern, M.; Schon, M.R.; Gartner, D.; Lohmann, T.; Dressler, M.; et al. Effects of Weight Loss on Glutathione Peroxidase 3 Serum Concentrations and Adipose Tissue Expression in Human Obesity. Obes. facts 2018, 11, 475–490. [Google Scholar] [CrossRef]
- Mauri, P.; Benazzi, L.; Flohe, L.; Maiorino, M.; Pietta, P.G.; Pilawa, S.; Roveri, A.; Ursini, F. Versatility of selenium catalysis in PHGPx unraveled by LC/ESI-MS/MS. Biol. Chem. 2003, 384, 575–588. [Google Scholar] [CrossRef]
- Friedmann Angeli, J.P.; Conrad, M. Selenium and GPX4, a vital symbiosis. Free Radic. Biol. Med. 2018, 127, 153–159. [Google Scholar] [CrossRef] [Green Version]
- Ingold, I.; Berndt, C.; Schmitt, S.; Doll, S.; Poschmann, G.; Buday, K.; Roveri, A.; Peng, X.; Porto Freitas, F.; Seibt, T.; et al. Selenium Utilization by GPX4 Is Required to Prevent Hydroperoxide-Induced Ferroptosis. Cell 2018, 172, 409–422.e421. [Google Scholar] [CrossRef] [Green Version]
- Stockwell, B.R.; Friedmann Angeli, J.P.; Bayir, H.; Bush, A.I.; Conrad, M.; Dixon, S.J.; Fulda, S.; Gascon, S.; Hatzios, S.K.; Kagan, V.E.; et al. Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease. Cell 2017, 171, 273–285. [Google Scholar] [CrossRef] [Green Version]
- Shema, R.; Kulicke, R.; Cowley, G.S.; Stein, R.; Root, D.E.; Heiman, M. Synthetic lethal screening in the mammalian central nervous system identifies Gpx6 as a modulator of Huntington’s disease. Proc. Natl. Acad. Sci. USA 2015, 112, 268–272. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Powis, G.; Mustacich, D.; Coon, A. The role of the redox protein thioredoxin in cell growth and cancer. Free Radic. Biol. Med. 2000, 29, 312–322. [Google Scholar] [CrossRef]
- Han, S.J.; Zhang, Y.; Kim, I.; Chay, K.O.; Yoon, H.J.; Jang, D.I.; Yang, S.Y.; Park, J.; Woo, H.A.; Park, I.; et al. Redox regulation of the tumor suppressor PTEN by the thioredoxin system and cumene hydroperoxide. Free Radic. Biol. Med. 2017, 112, 277–286. [Google Scholar] [CrossRef] [PubMed]
- Mustacich, D.; Powis, G. Thioredoxin reductase. Biochem. J. 2000, 346 Pt 1, 1–8. [Google Scholar] [CrossRef]
- Lu, J.; Holmgren, A. Selenoproteins. J. Boil. Chem. 2009, 284, 723–727. [Google Scholar] [CrossRef] [Green Version]
- Urig, S.; Becker, K. On the potential of thioredoxin reductase inhibitors for cancer therapy. Semin. Cancer Biol. 2006, 16, 452–465. [Google Scholar] [CrossRef]
- Cheng, Q.; Sandalova, T.; Lindqvist, Y.; Arner, E.S. Crystal structure and catalysis of the selenoprotein thioredoxin reductase 1. J. Boil. Chem. 2009, 284, 3998–4008. [Google Scholar] [CrossRef] [Green Version]
- Sandalova, T.; Zhong, L.; Lindqvist, Y.; Holmgren, A.; Schneider, G. Three-dimensional structure of a mammalian thioredoxin reductase: Implications for mechanism and evolution of a selenocysteine-dependent enzyme. Proc. Natl. Acad. Sci. USA 2001, 98, 9533–9538. [Google Scholar] [CrossRef] [Green Version]
- Biterova, E.I.; Turanov, A.A.; Gladyshev, V.N.; Barycki, J.J. Crystal structures of oxidized and reduced mitochondrial thioredoxin reductase provide molecular details of the reaction mechanism. Proc. Natl. Acad. Sci. USA 2005, 102, 15018–15023. [Google Scholar] [CrossRef] [Green Version]
- Fritz-Wolf, K.; Kehr, S.; Stumpf, M.; Rahlfs, S.; Becker, K. Crystal structure of the human thioredoxin reductase-thioredoxin complex. Nat. Commun. 2011, 2, 383. [Google Scholar] [CrossRef]
- Zhong, L.; Holmgren, A. Essential role of selenium in the catalytic activities of mammalian thioredoxin reductase revealed by characterization of recombinant enzymes with selenocysteine mutations. J. Boil. Chem. 2000, 275, 18121–18128. [Google Scholar] [CrossRef] [Green Version]
- Kumar, S.; Bjornstedt, M.; Holmgren, A. Selenite is a substrate for calf thymus thioredoxin reductase and thioredoxin and elicits a large non-stoichiometric oxidation of NADPH in the presence of oxygen. Eur. J. Biochem. 1992, 207, 435–439. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Lu, J.; Berndt, C.; Holmgren, A. Metabolism of selenium compounds catalyzed by the mammalian selenoprotein thioredoxin reductase. Biochim. Biophy. Acta 2009, 1790, 1513–1519. [Google Scholar] [CrossRef] [PubMed]
- May, J.M.; Mendiratta, S.; Hill, K.E.; Burk, R.F. Reduction of dehydroascorbate to ascorbate by the selenoenzyme thioredoxin reductase. J. Biol. Chem. 1997, 272, 22607–22610. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Nordberg, J.; Arner, E.S. Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic. Biol. Med. 2001, 31, 1287–1312. [Google Scholar] [CrossRef]
- Karlenius, T.C.; Tonissen, K.F. Thioredoxin and Cancer: A Role for Thioredoxin in all States of Tumor Oxygenation. Cancers 2010, 2, 209–232. [Google Scholar] [CrossRef] [Green Version]
- Arner, E.S.; Holmgren, A. Physiological functions of thioredoxin and thioredoxin reductase. Eur. J. Biochem. 2000, 267, 6102–6109. [Google Scholar] [CrossRef]
- Bjorkhem-Bergman, L.; Jonsson-Videsater, K.; Paul, C.; Bjornstedt, M.; Andersson, M. Mammalian thioredoxin reductase alters cytolytic activity of an antibacterial peptide. Peptides 2004, 25, 1849–1855. [Google Scholar] [CrossRef]
- Andersson, M.; Holmgren, A.; Spyrou, G. NK-lysin, a disulfide-containing effector peptide of T-lymphocytes, is reduced and inactivated by human thioredoxin reductase. Implication for a protective mechanism against NK-lysin cytotoxicity. J. Boil. Chem. 1996, 271, 10116–10120. [Google Scholar] [CrossRef] [Green Version]
- Nalvarte, I.; Damdimopoulos, A.E.; Spyrou, G. Human mitochondrial thioredoxin reductase reduces cytochrome c and confers resistance to complex III inhibition. Free Radic. Biol. Med. 2004, 36, 1270–1278. [Google Scholar] [CrossRef]
- Berggren, M.M.; Mangin, J.F.; Gasdaka, J.R.; Powis, G. Effect of selenium on rat thioredoxin reductase activity: Increase by supranutritional selenium and decrease by selenium deficiency. Biochem. Pharmacol. 1999, 57, 187–193. [Google Scholar] [CrossRef]
- Miller, S.; Walker, S.W.; Arthur, J.R.; Nicol, F.; Pickard, K.; Lewin, M.H.; Howie, A.F.; Beckett, G.J. Selenite protects human endothelial cells from oxidative damage and induces thioredoxin reductase. Cli. Sci. 2001, 100, 543–550. [Google Scholar] [CrossRef] [Green Version]
- Khan, I.A.; Luduena, R.F. Possible regulation of the in vitro assembly of bovine brain tubulin by the bovine thioredoxin system. Biochim. Biophys. Acta 1991, 1076, 289–297. [Google Scholar] [CrossRef]
- Shinozaki, Y.; Koizumi, S.; Ohno, Y.; Nagao, T.; Inoue, K. Extracellular ATP counteracts the ERK1/2-mediated death-promoting signaling cascades in astrocytes. Glia 2006, 54, 606–618. [Google Scholar] [CrossRef] [PubMed]
- Hellfritsch, J.; Kirsch, J.; Schneider, M.; Fluege, T.; Wortmann, M.; Frijhoff, J.; Dagnell, M.; Fey, T.; Esposito, I.; Kolle, P.; et al. Knockout of mitochondrial thioredoxin reductase stabilizes prolyl hydroxylase 2 and inhibits tumor growth and tumor-derived angiogenesis. Antioxid. Redox Signal. 2015, 22, 938–950. [Google Scholar] [CrossRef] [PubMed]
- Kondo, N.; Nakamura, H.; Masutani, H.; Yodoi, J. Redox regulation of human thioredoxin network. Antioxid. Redox Signal. 2006, 8, 1881–1890. [Google Scholar] [CrossRef]
- Arner, E.S. Focus on mammalian thioredoxin reductases--important selenoproteins with versatile functions. Biochim. Biophys. Acta 2009, 1790, 495–526. [Google Scholar] [CrossRef]
- Holmgren, A.; Lu, J. Thioredoxin and thioredoxin reductase: Current research with special reference to human disease. Biochem. Biophys. Res. Commun. 2010, 396, 120–124. [Google Scholar] [CrossRef] [Green Version]
- Gladyshev, V.N.; Stadtman, T.C.; Hatfield, D.L.; Jeang, K.T. Levels of major selenoproteins in T cells decrease during HIV infection and low molecular mass selenium compounds increase. Proc. Natl. Acad. Sci. USA 1999, 96, 835–839. [Google Scholar] [CrossRef] [Green Version]
- Wande, Y.; Jie, L.; Aikai, Z.; Yaguo, Z.; Linlin, Z.; Yue, G.; Hang, Z. Berberine alleviates pulmonary hypertension through Trx1 and beta-catenin signaling pathways in pulmonary artery smooth muscle cells. Exp. Cell. Res. 2020, 390, 111910. [Google Scholar] [CrossRef]
- Ago, T.; Sadoshima, J. Thioredoxin and ventricular remodeling. J. Mol. Cell. Cardiol. 2006, 41, 762–773. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kwon, J.; Lee, S.R.; Yang, K.S.; Ahn, Y.; Kim, Y.J.; Stadtman, E.R.; Rhee, S.G. Reversible oxidation and inactivation of the tumor suppressor PTEN in cells stimulated with peptide growth factors. Proc. Natl. Acad. Sci. USA 2004, 101, 16419–16424. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Lee, S.R.; Yang, K.S.; Kwon, J.; Lee, C.; Jeong, W.; Rhee, S.G. Reversible inactivation of the tumor suppressor PTEN by H2O2. J. Biol. Chem. 2002, 277, 20336–20342. [Google Scholar] [CrossRef] [Green Version]
- Meuillet, E.J.; Mahadevan, D.; Berggren, M.; Coon, A.; Powis, G. Thioredoxin-1 binds to the C2 domain of PTEN inhibiting PTEN’s lipid phosphatase activity and membrane binding: A mechanism for the functional loss of PTEN’s tumor suppressor activity. Arch. Biochem. Biophys. 2004, 429, 123–133. [Google Scholar] [CrossRef]
- Berggren, M.; Gallegos, A.; Gasdaska, J.R.; Gasdaska, P.Y.; Warneke, J.; Powis, G. Thioredoxin and thioredoxin reductase gene expression in human tumors and cell lines, and the effects of serum stimulation and hypoxia. Anticancer Res. 1996, 16, 3459–3466. [Google Scholar]
- Lincoln, D.T.; Ali Emadi, E.M.; Tonissen, K.F.; Clarke, F.M. The thioredoxin-thioredoxin reductase system: Over-expression in human cancer. Anticancer Res. 2003, 23, 2425–2433. [Google Scholar] [PubMed]
- Shao, L.; Diccianni, M.B.; Tanaka, T.; Gribi, R.; Yu, A.L.; Pullen, J.D.; Camitta, B.M.; Yu, J. Thioredoxin expression in primary T-cell acute lymphoblastic leukemia and its therapeutic implication. Cancer Res. 2001, 61, 7333–7338. [Google Scholar] [PubMed]
- Biaglow, J.E.; Miller, R.A. The thioredoxin reductase/thioredoxin system: Novel redox targets for cancer therapy. Cancer Biol. Ther. 2005, 4, 6–13. [Google Scholar] [CrossRef]
- Hashemy, S.I.; Ungerstedt, J.S.; Zahedi Avval, F.; Holmgren, A. Motexafin gadolinium, a tumor-selective drug targeting thioredoxin reductase and ribonucleotide reductase. J. Biol. Chem. 2006, 281, 10691–10697. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Smart, D.K.; Ortiz, K.L.; Mattson, D.; Bradbury, C.M.; Bisht, K.S.; Sieck, L.K.; Brechbiel, M.W.; Gius, D. Thioredoxin reductase as a potential molecular target for anticancer agents that induce oxidative stress. Cancer Res. 2004, 64, 6716–6724. [Google Scholar] [CrossRef] [Green Version]
- Duan, D.; Zhang, J.; Yao, J.; Liu, Y.; Fang, J. Targeting Thioredoxin Reductase by Parthenolide Contributes to Inducing Apoptosis of HeLa Cells. J. Biol. Chem. 2016. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Zou, P.; Xia, Y.; Chen, W.; Chen, X.; Ying, S.; Feng, Z.; Chen, T.; Ye, Q.; Wang, Z.; Qiu, C.; et al. EF24 induces ROS-mediated apoptosis via targeting thioredoxin reductase 1 in gastric cancer cells. Oncotarget 2016. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Witte, A.B.; Anestal, K.; Jerremalm, E.; Ehrsson, H.; Arner, E.S. Inhibition of thioredoxin reductase but not of glutathione reductase by the major classes of alkylating and platinum-containing anticancer compounds. Free Radic. Biol. Med. 2005, 39, 696–703. [Google Scholar] [CrossRef] [PubMed]
- Gromer, S.; Schirmer, R.H.; Becker, K. The 58 kDa mouse selenoprotein is a BCNU-sensitive thioredoxin reductase. FEBS Lett. 1997, 412, 318–320. [Google Scholar] [CrossRef] [Green Version]
- Wang, X.; Zhang, J.; Xu, T. Thioredoxin reductase inactivation as a pivotal mechanism of ifosfamide in cancer therapy. Eur. J. Pharmacol. 2008, 579, 66–73. [Google Scholar] [CrossRef] [PubMed]
- Wang, X.; Zhang, J.; Xu, T. Cyclophosphamide as a potent inhibitor of tumor thioredoxin reductase in vivo. Toxicol. Appl. Pharmacol. 2007, 218, 88–95. [Google Scholar] [CrossRef]
- Lu, J.; Chew, E.H.; Holmgren, A. Targeting thioredoxin reductase is a basis for cancer therapy by arsenic trioxide. Proc. Natl. Acad. Sci. USA 2007, 104, 12288–12293. [Google Scholar] [CrossRef] [Green Version]
- Fang, J.; Lu, J.; Holmgren, A. Thioredoxin reductase is irreversibly modified by curcumin: A novel molecular mechanism for its anticancer activity. J. Biol. Chem. 2005, 280, 25284–25290. [Google Scholar] [CrossRef] [Green Version]
- Lu, J.; Papp, L.V.; Fang, J.; Rodriguez-Nieto, S.; Zhivotovsky, B.; Holmgren, A. Inhibition of Mammalian thioredoxin reductase by some flavonoids: Implications for myricetin and quercetin anticancer activity. Cance. Res. 2006, 66, 4410–4418. [Google Scholar] [CrossRef] [Green Version]
- Xia, L.; Nordman, T.; Olsson, J.M.; Damdimopoulos, A.; Bjorkhem-Bergman, L.; Nalvarte, I.; Eriksson, L.C.; Arner, E.S.; Spyrou, G.; Bjornstedt, M. The mammalian cytosolic selenoenzyme thioredoxin reductase reduces ubiquinone. A novel mechanism for defense against oxidative stress. J. Biol. Chem. 2003, 278, 2141–2146. [Google Scholar] [CrossRef] [Green Version]
- Nordberg, J.; Zhong, L.; Holmgren, A.; Arner, E.S. Mammalian thioredoxin reductase is irreversibly inhibited by dinitrohalobenzenes by alkylation of both the redox active selenocysteine and its neighboring cysteine residue. J. Biol. Chem. 1998, 273, 10835–10842. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Martinez, Y.; Li, X.; Liu, G.; Bin, P.; Yan, W.; Mas, D.; Valdivie, M.; Hu, C.A.; Ren, W.; Yin, Y. The role of methionine on metabolism, oxidative stress, and diseases. Amino. Acids. 2017, 49, 2091–2098. [Google Scholar] [CrossRef] [PubMed]
- Bin, P.; Huang, R.; Zhou, X. Oxidation Resistance of the Sulfur Amino Acids: Methionine and Cysteine. Biomed. Res. Int. 2017, 2017, 9584932. [Google Scholar] [CrossRef] [PubMed]
- Jiang, B.; Moskovitz, J. The Functions of the Mammalian Methionine Sulfoxide Reductase System and Related Diseases. Antioxidants 2018, 7, 122. [Google Scholar] [CrossRef] [Green Version]
- Hansel, A.; Heinemann, S.H.; Hoshi, T. Heterogeneity and function of mammalian MSRs: Enzymes for repair, protection and regulation. J. Nutr. Biochem. 2005, 1703, 239–247. [Google Scholar] [CrossRef]
- Cao, L.; Zhang, L.; Zeng, H.; Wu, R.T.; Wu, T.L.; Cheng, W.H. Analyses of Selenotranscriptomes and Selenium Concentrations in Response to Dietary Selenium Deficiency and Age Reveal Common and Distinct Patterns by Tissue and Sex in Telomere-Dysfunctional Mice. J. Nutr. 2017, 147, 1858–1866. [Google Scholar] [CrossRef] [Green Version]
- Novoselov, S.V.; Kim, H.-Y.; Hua, D.; Lee, B.C.; Astle, C.M.; Harrison, D.E.; Friguet, B.; Moustafa, M.E.; Carlson, B.A.; Hatfield, D.L. Regulation of selenoproteins and methionine sulfoxide reductases A and B1 by age, calorie restriction, and dietary selenium in mice. Antioxid. Redox Signal. 2010, 12, 829–838. [Google Scholar] [CrossRef] [Green Version]
- Lourenço dos Santos, S.; Petropoulos, I.; Friguet, B. The Oxidized Protein Repair Enzymes Methionine Sulfoxide Reductases and Their Roles in Protecting against Oxidative Stress, in Ageing and in Regulating Protein Function. Antioxidants 2018, 7, 191. [Google Scholar] [CrossRef]
- Kaya, A.; Lee, B.C.; Gladyshev, V.N. Regulation of protein function by reversible methionine oxidation and the role of selenoprotein MsrB1. Antioxid. Redox Signal. 2015, 23, 814–822. [Google Scholar] [CrossRef] [Green Version]
- Hung, R.J.; Spaeth, C.S.; Yesilyurt, H.G.; Terman, J.R. SelR reverses Mical-mediated oxidation of actin to regulate F-actin dynamics. Nat. Cell. Biol. 2013, 15, 1445–1454. [Google Scholar] [CrossRef] [Green Version]
- Kawabata Galbraith, K.; Kengaku, M. Multiple roles of the actin and microtubule-regulating formins in the developing brain. Neurosci. Res 2019, 138, 59–69. [Google Scholar] [CrossRef] [PubMed]
- Tang, D.D. The Dynamic Actin Cytoskeleton in Smooth Muscle. Adv. Pharmacol 2018, 81, 1–38. [Google Scholar] [CrossRef] [PubMed]
- Gallop, J.L. Filopodia and their links with membrane traffic and cell adhesion. Semin. Cell. Dev. Biol. 2019. [Google Scholar] [CrossRef] [PubMed]
- Leinweber, B.D.; Leavis, P.C.; Grabarek, Z.; Wang, C.-L.A.; Morgan, K.G. Extracellular regulated kinase (ERK) interaction with actin and the calponin homology (CH) domain of actin-binding proteins. Biochem. J. 1999, 344, 117–123. [Google Scholar] [CrossRef] [PubMed]
- Fomenko, D.E.; Novoselov, S.V.; Natarajan, S.K.; Lee, B.C.; Koc, A.; Carlson, B.A.; Lee, T.H.; Kim, H.Y.; Hatfield, D.L.; Gladyshev, V.N. MsrB1 (methionine-R-sulfoxide reductase 1) knock-out mice: Roles of MsrB1 in redox regulation and identification of a novel selenoprotein form. J. Biol. Chem. 2009, 284, 5986–5993. [Google Scholar] [CrossRef] [Green Version]
- Kim, K.Y.; Kwak, G.H.; Singh, M.P.; Gladyshev, V.N.; Kim, H.Y. Selenoprotein MsrB1 deficiency exacerbates acetaminophen-induced hepatotoxicity via increased oxidative damage. Arch. Biochem. Biophys. 2017, 634, 69–75. [Google Scholar] [CrossRef]
- Jia, Y.; Zhou, J.; Liu, H.; Huang, K. Effect of methionine sulfoxide reductase B1 (SelR) gene silencing on peroxynitrite-induced F-actin disruption in human lens epithelial cells. Biochem. Biophys. Res. Commun. 2014, 443, 876–881. [Google Scholar] [CrossRef]
- Dai, J.; Liu, H.; Zhou, J.; Huang, K. Selenoprotein R Protects Human Lens Epithelial Cells against D-Galactose-Induced Apoptosis by Regulating Oxidative Stress and Endoplasmic Reticulum Stress. Int. J. Mol. Sci. 2016, 17, 231. [Google Scholar] [CrossRef]
- Lee, B.C.; Lee, S.G.; Choo, M.K.; Kim, J.H.; Lee, H.M.; Kim, S.; Fomenko, D.E.; Kim, H.Y.; Park, J.M.; Gladyshev, V.N. Selenoprotein MsrB1 promotes anti-inflammatory cytokine gene expression in macrophages and controls immune response in vivo. Sci. Rep. 2017, 7, 5119. [Google Scholar] [CrossRef]
- Achilli, C.; Ciana, A.; Minetti, G. Brain, immune system and selenium: A starting point for a new diagnostic marker for Alzheimer’s disease? Oxid. Med. Cell. Longev. 2018, 138, 223–226. [Google Scholar] [CrossRef]
- He, Q.; Li, H.; Meng, F.; Sun, X.; Feng, X.; Chen, J.; Li, L.; Liu, J. Methionine Sulfoxide Reductase B1 Regulates Hepatocellular Carcinoma Cell Proliferation and Invasion via the Mitogen-Activated Protein Kinase Pathway and Epithelial-Mesenchymal Transition. Oxid. Med. Cell. Longev. 2018, 2018, 5287971. [Google Scholar] [CrossRef] [PubMed]
- Li, H.; He, Q.; Meng, F.; Feng, X.; Chen, J.; Li, L.; Liu, J. Methionine sulfoxide reductase B1 regulates proliferation and invasion by affecting mitogen-activated protein kinase pathway and epithelial-mesenchymal transition in u2os cells. Biochem. Biophys. Res. Commun. 2018, 496, 806–813. [Google Scholar] [CrossRef] [PubMed]
- Han, S.J.; Lee, B.C.; Yim, S.H.; Gladyshev, V.N.; Lee, S.R. Characterization of mammalian selenoprotein o: A redox-active mitochondrial protein. PLoS One 2014, 9, e95518. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Sreelatha, A.; Yee, S.S.; Lopez, V.A.; Park, B.C.; Kinch, L.N.; Pilch, S.; Servage, K.A.; Zhang, J.; Jiou, J.; Karasiewicz-Urbanska, M.; et al. Protein AMPylation by an Evolutionarily Conserved Pseudokinase. Cell 2018, 175, 809–821.e819. [Google Scholar] [CrossRef] [Green Version]
- Dudkiewicz, M.; Szczepinska, T.; Grynberg, M.; Pawlowski, K. A novel protein kinase-like domain in a selenoprotein, widespread in the tree of life. PLoS One 2012, 7, e32138. [Google Scholar] [CrossRef] [Green Version]
- Yan, J.; Fei, Y.; Han, Y.; Lu, S. Selenoprotein O deficiencies suppress chondrogenic differentiation of ATDC5 cells. Cell Biol. Int. 2016. [Google Scholar] [CrossRef]
- Ye, Y.; Fu, F.; Li, X.; Yang, J.; Liu, H. Selenoprotein S Is Highly Expressed in the Blood Vessels and Prevents Vascular Smooth Muscle Cells From Apoptosis. J. Cell. Biochem. 2016, 117, 106–117. [Google Scholar] [CrossRef]
- Smith, M.H.; Ploegh, H.L.; Weissman, J.S. Road to ruin: Targeting proteins for degradation in the endoplasmic reticulum. Science 2011, 334, 1086–1090. [Google Scholar] [CrossRef] [Green Version]
- Liu, J.; Li, F.; Rozovsky, S. The intrinsically disordered membrane protein selenoprotein S is a reductase in vitro. Biochemistry 2013, 52, 3051–3061. [Google Scholar] [CrossRef] [Green Version]
- Zhang, N.; Jing, W.; Cheng, J.; Cui, W.; Mu, Y.; Li, K.; Lei, X. Molecular characterization and NF-kappaB-regulated transcription of selenoprotein S from the Bama mini-pig. Mol. Biol. Rep. 2011, 38, 4281–4286. [Google Scholar] [CrossRef]
- Fradejas, N.; Serrano-Perez Mdel, C.; Tranque, P.; Calvo, S. Selenoprotein S expression in reactive astrocytes following brain injury. Glia 2011, 59, 959–972. [Google Scholar] [CrossRef] [PubMed]
- Curran, J.E.; Jowett, J.B.; Elliott, K.S.; Gao, Y.; Gluschenko, K.; Wang, J.; Abel Azim, D.M.; Cai, G.; Mahaney, M.C.; Comuzzie, A.G.; et al. Genetic variation in selenoprotein S influences inflammatory response. Nat. Genet. 2005, 37, 1234–1241. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Du, S.; Liu, H.; Huang, K. Influence of SelS gene silence on beta-Mercaptoethanol-mediated endoplasmic reticulum stress and cell apoptosis in HepG2 cells. Biochim. Biophys. Acta 2010, 1800, 511–517. [Google Scholar] [CrossRef] [PubMed]
- Moustafa, M.E.; Antar, H.A. A bioinformatics approach to characterize mammalian selenoprotein T. Biochem. Genet. 2012, 50, 736–747. [Google Scholar] [CrossRef] [PubMed]
- Sengupta, A.; Carlson, B.A.; Labunskyy, V.M.; Gladyshev, V.N.; Hatfield, D.L. Selenoprotein T deficiency alters cell adhesion and elevates selenoprotein W expression in murine fibroblast cells. Biochem. Cell Biol. 2009, 87, 953–961. [Google Scholar] [CrossRef]
- Grumolato, L.; Ghzili, H.; Montero-Hadjadje, M.; Gasman, S.; Lesage, J.; Tanguy, Y.; Galas, L.; Ait-Ali, D.; Leprince, J.; Guerineau, N.C.; et al. Selenoprotein T is a PACAP-regulated gene involved in intracellular Ca2+ mobilization and neuroendocrine secretion. FASEB J. 2008, 22, 1756–1768. [Google Scholar] [CrossRef]
- Boukhzar, L.; Hamieh, A.; Cartier, D.; Tanguy, Y.; Alsharif, I.; Castex, M.; Arabo, A.; Hajji, S.E.; Bonnet, J.J.; Errami, M.; et al. Selenoprotein T Exerts an Essential Oxidoreductase Activity That Protects Dopaminergic Neurons in Mouse Models of Parkinson’s Disease. Antioxid. Redox Signal. 2016, 24, 557–574. [Google Scholar] [CrossRef]
- Petit, N.; Lescure, A.; Rederstorff, M.; Krol, A.; Moghadaszadeh, B.; Wewer, U.M.; Guicheney, P. Selenoprotein N: An endoplasmic reticulum glycoprotein with an early developmental expression pattern. Hum. Mol. Genet. 2003, 12, 1045–1053. [Google Scholar] [CrossRef] [Green Version]
- Lescure, A.; Gautheret, D.; Carbon, P.; Krol, A. Novel selenoproteins identified in silico and in vivo by using a conserved RNA structural motif. J. Biol. Chem. 1999, 274, 38147–38154. [Google Scholar] [CrossRef] [Green Version]
- Arbogast, S.; Beuvin, M.; Fraysse, B.; Zhou, H.; Muntoni, F.; Ferreiro, A. Oxidative stress in SEPN1-related myopathy: From pathophysiology to treatment. Ann. Neurol. 2009, 65, 677–686. [Google Scholar] [CrossRef]
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Zhang, Y.; Roh, Y.J.; Han, S.-J.; Park, I.; Lee, H.M.; Ok, Y.S.; Lee, B.C.; Lee, S.-R. Role of Selenoproteins in Redox Regulation of Signaling and the Antioxidant System: A Review. Antioxidants 2020, 9, 383. https://doi.org/10.3390/antiox9050383
Zhang Y, Roh YJ, Han S-J, Park I, Lee HM, Ok YS, Lee BC, Lee S-R. Role of Selenoproteins in Redox Regulation of Signaling and the Antioxidant System: A Review. Antioxidants. 2020; 9(5):383. https://doi.org/10.3390/antiox9050383
Chicago/Turabian StyleZhang, Ying, Yeon Jin Roh, Seong-Jeong Han, Iha Park, Hae Min Lee, Yong Sik Ok, Byung Cheon Lee, and Seung-Rock Lee. 2020. "Role of Selenoproteins in Redox Regulation of Signaling and the Antioxidant System: A Review" Antioxidants 9, no. 5: 383. https://doi.org/10.3390/antiox9050383
APA StyleZhang, Y., Roh, Y. J., Han, S. -J., Park, I., Lee, H. M., Ok, Y. S., Lee, B. C., & Lee, S. -R. (2020). Role of Selenoproteins in Redox Regulation of Signaling and the Antioxidant System: A Review. Antioxidants, 9(5), 383. https://doi.org/10.3390/antiox9050383